The Hippo signaling network and its biological functions

JR Misra, KD Irvine - Annual review of genetics, 2018 - annualreviews.org
Hippo signaling is an evolutionarily conserved network that has a central role in regulating
cell proliferation and cell fate to control organ growth and regeneration. It promotes …

Recent therapeutic approaches to modulate the Hippo pathway in oncology and regenerative medicine

ER Barry, V Simov, I Valtingojer, O Venier - Cells, 2021 - mdpi.com
The Hippo pathway is an evolutionary conserved signaling network that regulates essential
processes such as organ size, cell proliferation, migration, stemness and apoptosis …

[HTML][HTML] Glycogen accumulation and phase separation drives liver tumor initiation

Q Liu, J Li, W Zhang, C Xiao, S Zhang, C Nian, J Li… - Cell, 2021 - cell.com
Glucose consumption is generally increased in tumor cells to support tumor growth.
Interestingly, we report that glycogen accumulation is a key initiating oncogenic event during …

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression

C He, D Mao, G Hua, X Lv, X Chen… - EMBO molecular …, 2015 - embopress.org
The Hippo signaling pathway controls organ size and tumorigenesis through a kinase
cascade that inactivates Yes‐associated protein (YAP). Here, we show that YAP plays a …

YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma

MH Kim, CG Kim, SK Kim, SJ Shin, EA Choe… - Cancer immunology …, 2018 - AACR
Activation of YAP, a Hippo pathway effector, is an important resistance mechanism to BRAF
inhibitor (BRAFi) in melanoma. Emerging evidence also suggests that YAP is involved in …

The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer

S Song, S Honjo, J Jin, SS Chang, AW Scott… - Clinical Cancer …, 2015 - AACR
Purpose: Esophageal cancer is an aggressive malignancy and often resistant to therapy.
Overexpression of EGFR has been associated with poor prognosis of patients with …

[HTML][HTML] YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK–STAT3 signaling

R Gruber, R Panayiotou, E Nye, B Spencer-Dene… - Gastroenterology, 2016 - Elsevier
Background & Aims Pancreatitis is the most important risk factor for pancreatic ductal
adenocarcinoma (PDAC). Pancreatitis predisposes to PDAC because it induces a process …

Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival

E Rozengurt, J Sinnett-Smith, G Eibl - Signal transduction and targeted …, 2018 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is generally a fatal disease with no efficacious
treatment modalities. Elucidation of signaling mechanisms that will lead to the identification …

Differential growth triggers mechanical feedback that elevates Hippo signaling

Y Pan, I Heemskerk, C Ibar… - Proceedings of the …, 2016 - National Acad Sciences
Mechanical stress can influence cell proliferation in vitro, but whether it makes a significant
contribution to growth control in vivo, and how it is modulated and experienced by cells …

Targeting the Hippo pathway for breast cancer therapy

L Wu, X Yang - Cancers, 2018 - mdpi.com
Breast cancer (BC) is one of the most prominent diseases in the world, and the treatments
for BC have many limitations, such as resistance and a lack of reliable biomarkers. Currently …